Form D · Biotechnology
Rythera Therapeutics Inc.
Deerfield Beach, FL · CIK 0001904834
Offering snapshot reported Mar 23, 2022 · SEC filing
- Reported sold
- $1.25M Offering amount: $3M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Mar 10, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 23, 2022 | Initial | $1,250,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-438606
Source: Form D, filed Mar 23, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rhonda Bhagwandeen | Executive |
| Dan Browne | Director, Executive |
| Marc Graboyes | Director, Executive |
| Reginald Hardy | Director, Executive |
| Stephen Hoffman | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
461 E Hillsboro Blvd. Suite 100 3
Deerfield Beach, FL, 33441
Deerfield Beach, FL, 33441